Education
About Us
Working with TipRanks
Follow Us
Semnur Pharmaceuticals (SMNR)
OTHER OTC:SMNR
SMNR Stock Chart & Stats
$9.00
--
Market closed
$9.00
--
Day’s Range― - ―
52-Week Range$9.00 - $20.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)31.00
Market Cap
$2.07B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding229,740,980
10 Day Avg. Volume0
30 Day Avg. Volume31
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Semnur Pharmaceuticals News
SMNR FAQ
What was Semnur Pharmaceuticals’s price range in the past 12 months?
Semnur Pharmaceuticals lowest stock price was $9.00 and its highest was $20.00 in the past 12 months.
What is Semnur Pharmaceuticals’s market cap?
Semnur Pharmaceuticals’s market cap is $2.07B.
When is Semnur Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Semnur Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Semnur Pharmaceuticals overvalued?
According to Wall Street analysts Semnur Pharmaceuticals’s price is currently Overvalued.
Does Semnur Pharmaceuticals pay dividends?
Semnur Pharmaceuticals does not currently pay dividends.
What is Semnur Pharmaceuticals’s EPS estimate?
Semnur Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Semnur Pharmaceuticals have?
Semnur Pharmaceuticals has 229,740,980 shares outstanding.
What happened to Semnur Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Semnur Pharmaceuticals?
Currently, no hedge funds are holding shares in SMNR
Semnur Pharmaceuticals Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 710.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $200.0M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-22.27%
12-Months-Change
Fundamentals
Return on Equity
-9.04%
Trailing 12-Months
Asset Growth
-98.92%
Trailing 12-Months
Company Description
Semnur Pharmaceuticals
Denali Capital Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. It intends to complete a business combination with companies primarily operating in the technology, consumer, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.